Clinical Trial Update: Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Epidermal Growth Factor for preventing or treating oral mucositis in patients undergoing intensive chemotherapy for hematologic maligna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Epidermal Growth Factor (epidermal growth factor)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Oral Mucositis | Phase 2 | Status: COMPLETED